NUS Magnetic Pulse Therapy Eradicates Tumors in 75% of Preclinical Trials
Singapore – September 16, 2026 -- Researchers at the National University of Singapore (NUS) have eradicated tumours in 75 per cent of tested preclinical models using pulsed electromagnetic fields (PEMFs) alone, without chemotherapy, after just four 30-minute sessions. The study, led by Associate Professor Alfredo Franco-Obregón of the NUS Yong Loo Lin School of Medicine, was published in the journal Smart Medicine on June 4, 2026.
PEMF device already cleared Phase 1 human safety trials
The same PEMF device used in the study has completed Phase 1 clinical trials, confirming its safety in humans. The NUS team is now seeking partners to fund and conduct Phase 2 efficacy trials to evaluate treatment performance in patients.